New Blood Pressure Guidelines Aim to Protect Kidney Health
Maya Rosenberg
The National Kidney Foundation emphasizes early kidney testing in managing high blood pressure, highlighting new guidelines that integrate kidney health into cardiovascular risk assessments.
The National Kidney Foundation has highlighted a new commentary from the Kidney Disease Outcomes Quality Initiative (KDOQI) focusing on integrating kidney health into the management of high blood pressure. The commentary is aligned with the 2025 guidelines from the American Heart Association and the American College of Cardiology, emphasizing the need for early and routine testing for kidney disease, especially among those with high blood pressure. Kidney damage can complicate blood pressure management, and earlier detection can facilitate better health outcomes.
Key recommendations include adopting urine albumin-to-creatinine ratio (uACR) testing, which can signal kidney damage long before a decline in kidney function is apparent. This comes as new data reveals that less than 10% of high blood pressure patients receive uACR testing, pointing to a critical gap in preventive care. The guidelines also adopt the PREVENT cardiovascular risk calculator, integrating kidney function data to better assess heart disease and stroke risks.
Effective Blood Pressure Control
The commentary underscores the symbiotic relationship between blood pressure and kidney health. According to Dr. Kerry Willis, Chief Scientific Officer at NKF, regular kidney testing should become a staple of blood pressure management to allow early detection and informed treatment of kidney disease. Accurate blood pressure readings, achieved through correct cuff sizing, patient positioning, and multiple readings, are crucial for making effective treatment decisions.
Dr. Tara I. Chang of Stanford University emphasizes that combining kidney function data with urine albumin results provides valuable insights beyond traditional blood pressure readings. The guidelines recommend a blood pressure target below 130/80, along with attention to factors such as treatment tolerance and evidence limitations for patients with advanced kidney disease.
Implications for Public Health Policy
For public health officials and policymakers, these guidelines call for widespread adoption of kidney testing among high blood pressure patients, addressing a major public health gap. The underutilization of key diagnostic tests remains a crucial barrier in early CKD detection. Crafting policies that encourage or mandate testing could significantly improve health outcomes for at-risk groups, particularly those in underserved communities.
Healthcare providers and systems are encouraged to adopt a multidisciplinary approach to manage blood pressure and kidney health, involving nephrologists, cardiologists, pharmacists, and primary care providers. Collaborative care models could prevent progression to kidney failure, reduce the burden on healthcare systems, and improve quality of life for patients. Prioritizing equitable access to these tests and treatments is essential to combat the disparities evident in CKD risk, notably among communities of color.
Questions That Matter
What new guidance does NKF emphasize?
The National Kidney Foundation highlights the new KDOQI commentary, which emphasizes early kidney testing and accurate blood pressure management. The guidelines urge the use of urine albumin-to-creatinine ratio testing for high blood pressure patients to identify early signs of kidney damage.
What does uACR testing detect?
Urine albumin-to-creatinine ratio (uACR) testing detects protein in urine, indicating potential kidney damage before noticeable declines in kidney function occur. Only about 10% of patients with high blood pressure receive this essential testing, highlighting a gap in early detection.